AMCP 2019 Street Team: Cate Lockhart of Biologics and Biosimilars Collective Intelligence Consortium

The FDA has made three approvals this week: a novel drug for dry eye disease, a new indication for Prevymis to prevent CMV disease in adult kidney transplant recipients, and another prostate cancer indication for Lynparza. The agency has also set target action dates for the first CRISPR gene edited therapy and a supplement indication for Jemperli for earlier treatment of endometrial cancer. Additionally, Janssen submitted sBLA for Carvykti for early treatment of myeloma.

Briana Contreras of MHE spoke with Leah Dewey of Cotiviti in this month’s podcast episode about what she’s seeing as the process of Medicaid Redetermination is well underway.

The company paved the way for prescription digital therapeutics.

This month’s episode of the "What's On Your Mind" podcast series features Eric Hunter, president and CEO of CareOregon. MHE Managing Editor Peter Wehrwein, Editor Briana Contreras and Hunter discuss Medicaid redetermination and merger of CareOregon and the California-based insurer, SCAN Group.

An overwhelming majority of survey respondents (93%) said aging in place is an important goal of theirs. Aging in place is considered the ability to live in one’s home and community safely, independently, and comfortably, regardless of age, income or ability level, according to the CDC.

Results of Sanofi-sponsored study presented at ISPOR meeting also show lower hospitalization rates among app users.